United States HR 4398: Affordable Prescriptions for Patients Through Promoting Competition Act of 2019

Status: Referred to the Subcommittee on Antitrust, Commercial, and Administrative Law. (as of 2019-10-02)

State: United States · Session: 116 · Bill: HR 4398

Subjects: Administrative remedies, Civil actions and liability, Competition and antitrust, Consumer affairs, Drug safety, medical device, and laboratory regulation, Federal Trade Commission (FTC), Health care costs and insurance, Inflation and prices, Intellectual property, Judicial review and appeals, Manufacturing, Prescription drugs

Sponsors: David N. Cicilline

View United States HR 4398 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.